Emerging Market Strategies - Mapping the opportunities for pharmaceutical expansion
出 版 商：CBR Pharma Insights
出版日期：2010/04/15
頁 數：54頁
文件格式：PDF
價 格：
USD 3,900 (Single-User License)
USD 4,900 (Multi-User License)
USD 9,800 (Global-User License)
USD 4,900 (Multi-User License)
USD 9,800 (Global-User License)
Emerging Market Strategies - Mapping the opportunities for pharmaceutical expansion
Summary
With a variety of factors impacting pharmaceutical growth in the traditional markets (the US, 5EU and Japan) – price controls, moves towards generics, healthcare reform, market saturation – the emerging markets (EMs) hold increasing potential to drive future product sales and overall company revenues.
The different situations which exist within each emerging market offer a wide variety of opportunities along with their own set of accompanying challenges. In order to best break in and position themselves within the various emerging markets, pharmaceutical companies are employing several different strategies. These strategies include: sales force growth, tiered pricing, generics, acquisitions/partnerships and an urban vs. rural focus.
The Emerging Markets Strategies report assesses why companies are looking outside of the traditional markets for company growth, the overall potential within the EMs, and the various strategies that are used to accomplish their long term goals. Additionally, CBR Pharma Insights looks at the opportunities and challenges which exist in the major, and the up & coming, emerging markets.
Scope
- Factors driving the, and strategies for, expansion into emerging markets
- Potential and Pitfalls in the Major Emerging Markets
- The Future for Emerging Markets – Analysis of top 6 countries - Argentina, Mexico, Poland, Saudi Arabia, South Africa, South Korea
Reasons to buy
- Use this report to identify the key entry strategies that are most appropriate for the different emerging markets
- Navigate the potential pitfalls that exist within the major emerging markets
- Pinpoint which of the newer emerging markets might be the most appropriate for your organization to target and which hold the potential for long term growth
- Compare and assess the efforts of other pharmaceutical companies in their expansion into new markets
- Understand the factors that are driving pharmaceutical companies to explore emerging markets
- Utilize extremely user-friendly, insight driven content to support key projects, presentations, and decisions within your organization
Summary
With a variety of factors impacting pharmaceutical growth in the traditional markets (the US, 5EU and Japan) – price controls, moves towards generics, healthcare reform, market saturation – the emerging markets (EMs) hold increasing potential to drive future product sales and overall company revenues.
The different situations which exist within each emerging market offer a wide variety of opportunities along with their own set of accompanying challenges. In order to best break in and position themselves within the various emerging markets, pharmaceutical companies are employing several different strategies. These strategies include: sales force growth, tiered pricing, generics, acquisitions/partnerships and an urban vs. rural focus.
The Emerging Markets Strategies report assesses why companies are looking outside of the traditional markets for company growth, the overall potential within the EMs, and the various strategies that are used to accomplish their long term goals. Additionally, CBR Pharma Insights looks at the opportunities and challenges which exist in the major, and the up & coming, emerging markets.
Scope
- Factors driving the, and strategies for, expansion into emerging markets
- Potential and Pitfalls in the Major Emerging Markets
- The Future for Emerging Markets – Analysis of top 6 countries - Argentina, Mexico, Poland, Saudi Arabia, South Africa, South Korea
Reasons to buy
- Use this report to identify the key entry strategies that are most appropriate for the different emerging markets
- Navigate the potential pitfalls that exist within the major emerging markets
- Pinpoint which of the newer emerging markets might be the most appropriate for your organization to target and which hold the potential for long term growth
- Compare and assess the efforts of other pharmaceutical companies in their expansion into new markets
- Understand the factors that are driving pharmaceutical companies to explore emerging markets
- Utilize extremely user-friendly, insight driven content to support key projects, presentations, and decisions within your organization
Executive Summary
Why the Drive to Emerging Markets?
Factors Slowing Growth in Traditional Markets
The Potential in Emerging Markets
Strategies for Expansion in Emerging Markets
Sales Force Growth
Tiered Pricing
Generics
Partnerships/Acquisitions
Urban v Rural Focus
Potential and Pitfalls in the Major Emerging Markets
Brazil
China
India
Russia
Turkey
The Future for Emerging Markets – 6 Countries to Watch
Argentina
Mexico
Poland
Saudi Arabia
South Africa
South Korea
Appendix
Why the Drive to Emerging Markets?
Factors Slowing Growth in Traditional Markets
The Potential in Emerging Markets
Strategies for Expansion in Emerging Markets
Sales Force Growth
Tiered Pricing
Generics
Partnerships/Acquisitions
Urban v Rural Focus
Potential and Pitfalls in the Major Emerging Markets
Brazil
China
India
Russia
Turkey
The Future for Emerging Markets – 6 Countries to Watch
Argentina
Mexico
Poland
Saudi Arabia
South Africa
South Korea
Appendix
